Terfenadine and placebo compared in the treatment of chronic idiopathic urticaria: a randomised double-blind study.

Abstract	Terfenadine, a potent and non-sedative antihistamine, was shown to be effective in chronic idiopathic urticaria in a double-blind crossover placebo controlled trial. An oral twice daily 60 mg dose of terfenadine was given and itch and wheal parameters were assessed daily. Despite the overall effectiveness of terfenadine, a variable response was noted which was similar to that shown in previous studies with other antihistamines.
Authors	J Ferguson, K J MacDonald, K J Kenicer
Journal	British journal of clinical pharmacology (Br J Clin Pharmacol) Vol. 20 Issue 6 Pg. 639-41 (Dec 1985) ISSN: 0306-5251 [Print] England
PMID	3937549 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References	Benzhydryl Compounds Terfenadine
Topics	Adult Aged Benzhydryl Compounds (adverse effects, therapeutic use) Chronic Disease Clinical Trials as Topic Double-Blind Method Female Humans Male Middle Aged Random Allocation Terfenadine Urticaria (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!